Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Harmony Biosciences Holdings (HRMY) is now available.
Jack Bech Nielsen has resigned with immediate effect from the Board of Harmony Biosciences Holdings, Inc. due to health reasons, with no disagreements cited regarding company operations. Meanwhile, Harmony Biosciences Holdings, Inc. has renamed its subsidiary from “Zynerba Pharmaceuticals, Inc.” to “Harmony Biosciences Management, Inc.” as of July 1, 2024.
For detailed information about HRMY stock, go to TipRanks’ Stock Analysis page.